文献速递细菌感染、耐药与抗菌药物

意大利伦巴第地区医院抗菌药物消耗趋势(2017-2024):基于区域行政数据的回顾性分析

In-hospital antibiotic consumption in Lombardy, Italy (2017-2024): a retrospective analysis of regional administrative data.
PubMed 文献 · J Antimicrob Chemother · 2026-01-01

该研究基于意大利伦巴第地区2017-2024年区域行政数据,回顾性分析医院抗菌药物消耗(AC)趋势及COVID-19影响。AC以每100住院日的DDD(绝对AC)、Access/Watch/Reserve抗生素相对比例、Access-to-Watch指数等表达,按病房类型(内科、外科、ICU)和时间段分层。结果显示总AC上升,相对Access比例升高而Watch下降,但WHO 2023年Access≥60%目标未达成,Reserve抗生素增加超出预期,尤以内科和ICU为著。

要点

  • 2017-2024年伦巴第医院总抗菌药物消耗上升,相对Access比例增加而Watch下降。
  • WHO 2023年Access≥60%目标未达成,Access-to-Watch指数除外科外均持续<1。
  • Reserve抗生素随时间、时段和病房类型增加,超出疫情前数据投影的预期水平。

核心结论

  • 2017-2024年伦巴第医院抗菌药物消耗发生显著变化,Reserve抗生素增加令人担忧,且持续未达WHO 2023年Access≥60%目标,尤其在内科和ICU,提示后疫情时代需强化抗菌药物管理政策。

研究设计与样本

  • 基于意大利伦巴第地区2017-2024年区域行政数据的回顾性分析,按病房类型(内科、外科、ICU)和时间段(疫情前、疫情初期、疫情期间、后疫情期)分层。

主要发现

  • 2017-2024年总AC激增,但相对Access AC上升而相对Watch AC下降,Access-to-Watch和Access-to-(Watch+Reserve)指数增加,ICU除外。
  • COVID-19初期观察到上述有利趋势的短暂逆转。
  • WHO 2023年Access≥60%目标未达成,Access-to-Watch和Access-to-(Watch+Reserve)指数除外科外持续<1。
  • 后疫情期Access-to-Watch和Access-to-(Watch+Reserve)指数呈下降趋势。
  • Reserve AC随时间、时段和病房类型增加,超出基于疫情前数据投影的预期水平。

关键数值与推荐

  • AC以每100住院日的DDD表示(绝对AC),并计算Access/Watch/Reserve抗生素相对比例、Access-to-Watch指数和Access-to-(Watch+Reserve)指数。
  • WHO 2023年目标为总AC中Access抗生素占比≥60%,本研究未达成。
  • Access-to-Watch和Access-to-(Watch+Reserve)指数除外科外持续<1。

临床怎么用

  • 应加强后疫情时代抗菌药物管理政策,尤其针对内科和ICU,以促进Access抗生素使用并控制Reserve抗生素增长。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Antimicrobial stewardship (AMS) is essential to tackle antimicrobial resistance. Antibiotic consumption (AC) surveillance provides evidence to guide AMS interventions. This study investigated in-hospital AC trends in Lombardy, Italy (2017-2024), with particular focus on the impact of COVID-19. METHODS: AC was expressed as DDDs per 100 bed days (absolute AC), relative proportions of Access/Watch/Reserve antibiotics (relative AC), Access-to-Watch index, and Access-to-(Watch + Reserve) index. Analyses were stratified by ward type-medical (MUs), surgical (SUs), and intensive care units (ICUs)-and timeframes: pre-COVID-19 (01/2017-02/2020), COVID-19 onset (02-03/2020), COVID-19 (03/2020-05/2023), and post-COVID-19 (05/2023-12/2024). RESULTS: Despite a surge in total AC in 2017-2024, relative Access AC rose while relative Watch AC declined, resulting in an increase of the Access-to-Watch and Access-to-(Watch + Reserve) indexes, except in ICUs. A transient reversal of such favourable trends was observed at COVID-19 onset. Nevertheless, the WHO 2023 target of ≥60% total AC being Access was not achieved; furthermore, Access-to-Watch and Access-to-(Watch + Reserve) indexes constantly remained <1, except for SUs. A downward trend in Access-to-Watch and Access-to-(Watch + Reserve) indexes was registered in the post-pandemic period. Reserve AC increased across time, periods and wards, exceeding the expected levels obtained using projections from pre-COVID-19 data. CONCLUSIONS: These findings highlight substantial shifts in in-hospital AC in Lombardy during the period 2017-2024, with concerning increases in Reserve antibiotics and an enduring failure to meet the 2023 WHO target of ≥60% Access antibiotics especially in MUs and ICUs, underscoring the need for reinforced AMS policies in the post-pandemic era.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Augello M, Cartabia M, Azab M, et al. In-hospital antibiotic consumption in Lombardy, Italy (2017-2024): a retrospective analysis of regional administrative data. J Antimicrob Chemother. 2026. PMID: 42702569. doi:10.1093/jac/dkag314

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。